Novus Biologicals™ Carbonic Anhydrase IX/CA9 Antibody (girentuximab-MMAE) - Chimeric, Novus Biologicals™
Human Monoclonal Antibody
Manufacturer: Fischer Scientific
The price for this product is unavailable. Please request a quote
Antigen
Carbonic Anhydrase IX/CA9
Applications
Flow Cytometry, ELISA, Functional Assay
Conjugate
Unconjugated
Host Species
Human
Research Discipline
Cancer, HIF Target Genes, Hypoxia, Lipid and Metabolism, Metastasis, Renal Cell Carcinoma Cell Markers
Formulation
Lyophilized from 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
Gene Alias
CAIX, CA-IX, Carbonate dehydratase IX, carbonic anhydrase 9, carbonic anhydrase IX, carbonic dehydratase, EC 4.2.1.1, G250, Membrane antigen MN, MN, P54/58N, PMW1, RCC-associated antigen G250, RCC-associated protein G250, Renal cell carcinoma-associated antigen G250
Immunogen
CA9/ CAIX
Primary or Secondary
Primary
Reconstitution
Reconstitute with sterile, distilled water to a final concentration of 1 mg/mL. Gently shake to solubilize completely. Do not vortex.
Clone
girentuximab-MMAE
Classification
Monoclonal
Form
Purified
Regulatory Status
RUO
Target Species
Human
Gene Accession No.
Q16790
Gene ID (Entrez)
768
Isotype
IgG1
Purification Method
Protein A purified
Content And Storage
Store at -20°C in powder form. Store at -80°C once reconstituted.
Related Products
Description
- Carbonic Anhydrase IX/CA9 Monoclonal antibody specifically detects Carbonic Anhydrase IX/CA9 in Human samples
- It is validated for Flow Cytometry,ELISA,Functional Assay